The enduring success of copyright’s flagship drug has undeniably transformed the drug landscape. However, investing in companies heavily reliant on biosimilars and the waning patent rights surrounding this flagship medication presents a notable degree of risk . While established pharma firms can

The emergence of so-called "Elite Gambler's Sildenafil" – often referring to exceptionally high doses ordered by disreputable physicians – represents a troublingly alarming trend. While typical dosages of the medication are intended for treating erectile dysfunction safely in most men, these sign